supported by the National Key Research and Development Program of China(2016YFA0201504);National Natural Science Foundation of China(No.81473249 and81102464);the National Mega-project for Innovative Drugs(2014ZX09201042,China);the CAMS Innovation Fund for Medical Sciences(CIFMS,2016-I2M-2-002,China);Drug Innovation Major Project of China(2018ZX09711001-007-002)。
Pancreatic adenocarcinoma(PAAD) is one of the most lethal malignancies. Although gemcitabine(GEM) is a standard treatment for PAAD, resistance limits its application and therapy. Secoemestrin C(Sec C) is a natural com...
supported by the National Key Research and Development Program of China(2016YFA0201504);National Natural Science Foundation of China(No.81673471,81102464);the CAMS Initiative for Innovative Medicine(2016-I2M-2-002);the Drug Innovation Major Project of China(2018ZX09711001-007-002).
Ras-GTPase activating SH3 domain-binding protein 1(G3BP1)is a multifunctional binding protein involved in the development of a variety of human cancers.However,the role of G3BP1 in breast cancer progression remains la...
the National Key Research and Development Program of China(2016YFA0201504);National Natural Science Foundation of China(Nos.81473249 and 81102464);the National Mega-project for Innovative Drugs(2014ZX09201042);the CAMS Innovation Fund for Medical Sciences(CIFMS)(2016-I2M-2-002);Drug Innovation Major Project of China(2018ZX09711001-007-002).
Sophoridine is a quinolizidine natural product and the exploration of its derivatives has been carried out,and the potent anticancer compound IMB-HDC was acquired.Although previous studies have revealed that some soph...